These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15721499)

  • 1. Reducing atrial tachycardia and atrial fibrillation episodes with a prevention and treatment device and tailored treatment.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Mar; 99(1):51-8. PubMed ID: 15721499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Martinek M; Aichinger J; Nesser HJ; Ziegler PD; Purerfellner H
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording.
    de Voogt WG; van Hemel NM; van de Bos AA; Koïstinen J; Fast JH
    Europace; 2006 Nov; 8(11):950-61. PubMed ID: 17043069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation.
    Pürerfellner H; Urban L; de Weerd G; Ruiter J; Brandt J; Havlicek A; Hügl B; Widdershoven J; Kornet L; Kessels R
    Europace; 2009 Jan; 11(1):62-9. PubMed ID: 19008238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables.
    Quirino G; Giammaria M; Corbucci G; Pistelli P; Turri E; Mazza A; Perucca A; Checchinato C; Dalmasso M; Barold SS
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):91-8. PubMed ID: 19140918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up.
    Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD
    Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry.
    Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation.
    Mitchell AR; Spurrell PA; Sulke N
    Am Heart J; 2003 Nov; 146(5):902-7. PubMed ID: 14597942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features.
    Hoffmann E; Sulke N; Edvardsson N; Ruiter J; Lewalter T; Capucci A; Schuchert A; Janko S; Camm J;
    Circulation; 2006 Apr; 113(16):1933-41. PubMed ID: 16636187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.
    Gillis AM; Morck M; Exner DV; Soo A; Rose MS; Sheldon RS; Duff HJ; Kavanagh KM; Mitchell LB; Wyse DG
    Eur Heart J; 2008 Aug; 29(15):1873-80. PubMed ID: 18477727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
    Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL
    Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.